Grants per year
Personal profile
Research Interests
Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
Certifications and Licenses
| Anatomic Pathology |
Training Experience
| 1994 | Residency, Beth Israel Deaconess Medical Center, Boston |
| 1995 | Fellowship, Beth Israel Deaconess Medical Center, Boston |
Education/Academic qualification
PhD, Rush Medical College
… → 1990
MD, Aristotle's University of Thessaloniki
… → 1985
Research interests
- Breast Cancer
- Breast Disease
- Cancer Biology
- Pathology
Fingerprint Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Breast
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Carcinoma, Ductal, Breast
Medicine & Life Sciences
Estrogen Receptors
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Alveolar Macrophages
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2014 2016
- 1 Finished
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
Cheng, C., Cheng, S. & Siziopikou, K. P.
2/4/14 → 5/31/16
Project: Research project
Research Output 1990 2019
1
Citation
(Scopus)
The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast
Ubago, J. M., Blanco Jr, L. Z., Shen, T. & Siziopikou, K. P., Jul 5 2019, In : American journal of clinical pathology. 152, 2, p. 169-176 8 p.Research output: Contribution to journal › Article
Carcinoma, Intraductal, Noninfiltrating
Epidermal Growth Factor
Breast
Ligands
Tumor-Infiltrating Lymphocytes
Double-equivocal HER2 invasive breast carcinomas: Institutional experience and review of literature
Griffin, B. B., Pincus, J. L., Siziopikou, K. P. & Blanco, L. Z., Dec 2018, In : Archives of Pathology and Laboratory Medicine. 142, 12, p. 1511-1516 6 p.Research output: Contribution to journal › Article
Fluorescence In Situ Hybridization
Reflex
Breast Neoplasms
Chromosomes, Human, Pair 17
Immunohistochemistry
11
Citations
(Scopus)
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy
Jain, S., Shah, A. N., Santa-Maria, C. A., Siziopikou, K. P., Rademaker, A. W., Helenowski, I., Cristofanilli, M. & Gradishar, W. J., Sep 1 2018, In : Breast Cancer Research and Treatment. 171, 2, p. 371-381 11 p.Research output: Contribution to journal › Article
1-Phosphatidylinositol 4-Kinase
Breast Neoplasms
Maximum Tolerated Dose
Exanthema
Disease-Free Survival
25
Citations
(Scopus)
IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity
Chiang, S., Weigelt, B., Wen, H. C., Pareja, F., Raghavendra, A., Martelotto, L. G., Burke, K. A., Basili, T., Li, A., Geyer, F. C., Piscuoglio, S., Ng, C. K. Y., Jungbluth, A. A., Balss, J., Pusch, S., Baker, G. M., Cole, K. S., Von Deimling, A., Batten, J. M., Marotti, J. D. & 13 others, , Dec 15 2016, In : Cancer Research. 76, 24, p. 7118-7129 12 p.Research output: Contribution to journal › Article
Papillary Carcinoma
Breast Neoplasms
Mutation
Exome
Isocitrate Dehydrogenase
95
Citations
(Scopus)
Phyllodes tumours of the breast: A consensus review
Tan, B. Y., Acs, G., Apple, S. K., Badve, S., Bleiweiss, I. J., Brogi, E., Calvo, J. P., Dabbs, D. J., Ellis, I. O., Eusebi, V., Farshid, G., Fox, S. B., Ichihara, S., Lakhani, S. R., Rakha, E. A., Reis-Filho, J. S., Richardson, A. L., Sahin, A., Schmitt, F. C., Schnitt, S. J. & 5 others, , Jan 1 2016, In : Histopathology. 68, 1, p. 5-21 17 p.Research output: Contribution to journal › Review article
Phyllodes Tumor
Consensus
Breast
Fibroadenoma
Neoplasm Grading